Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRAZIL-TNT: FOLFIRINOX in Locally Advanced Rectal Cancer
NCT05081687Phase 3Unknown
- Sponsor
- Hospital Israelita Albert Einstein
- Start
- Feb 2020
- Primary completion
- Nov 2023
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of fluorouracil, oxaliplatin, irinotecan in rectal cancer, sponsored by Hospital Israelita Albert Einstein. Status: unknown.
02
Drugs
fluorouraciloxaliplatinirinotecan
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT05081687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05081687.